BeStock  

Zoetis ZTS

US equityMarket cap rank #616Drug Manufacturers - Specialty & Generic
$79.11 −$1.68 (-2.08%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $78.16 -1.20%
Open$81.73
Prev close$80.79
Day range$78.80 – $83.08
Volume6.10M
Market cap$32.14B
P/E (TTM)13.3
Dividend yield2.64%

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.9%-0.01 pts vs. prior quarter
Institutions holding1,752-6 vs. prior quarter
Insider trades (recent)41 buys / 5 sellsNet buying
Short interest4.05% of floatDays to cover 4.8 · as of 30 Oct 2026
Short-sale volume share13.2%5-day average of daily volume

Short-sale volume as % of daily volume

7%12%17%23%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$10.50M (8 inflow days, 12 outflow days).

Net flow by order size, last 20 sessions

+$7.2MSuper−$17.7MBig−$16.8MMid−$54.6MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 30.9% of shares outstanding.

Largest holders

  • BlackRock9.48%
  • Vanguard Capital Management, LLC6.90%
  • Vanguard Portfolio Management, LLC5.78%
  • State Street Global Advisors4.85%
  • State Farm Mutual Automobile Insurance Company3.91%
  • Geode Capital Management, LLC3.27%
  • Fidelity International Ltd2.62%
  • Wellington Management Group2.28%

By investor type

  • Mutual Fund76.07%
  • Private Company7.35%
  • Public Company4.81%
  • Hedge Fund3.78%
  • Government Pension Fund2.23%
  • Sovereign Wealth Fund1.21%
  • Family Office/Trust0.53%
  • VC/PE Fund0.47%

Reported short interest has held roughly steady near 4.05% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Fidelity International Ltd Mutual Fund 2026/Q4 +5,260,465 2.6%
Davis Selected Advisers LP Mutual Fund 2026/Q4 +3,569,821 0.9%
J.P. Morgan Asset Management, Inc. Mutual Fund 2026/Q4 +1,902,690 0.8%
Invesco Ltd. Mutual Fund 2026/Q4 +1,816,616 0.9%
Victory Capital Management Inc. Mutual Fund 2026/Q4 +1,414,202 0.9%
Confluence Investment Management LLC Mutual Fund 2026/Q4 +1,398,638 0.5%
Van Eck Associates Corporation Mutual Fund 2026/Q4 +1,143,240 1.3%
Goldman Sachs Asset Management, L.P. Mutual Fund 2026/Q4 +958,456 0.6%
Stifel Asset Management Corp. Mutual Fund 2026/Q4 +812,241 0.3%
Deka Investment GmbH Mutual Fund 2026/Q4 +805,491 0.3%
JPMorgan Chase & Co. Public Company 2026/Q4 +798,353 0.4%
First Eagle Investment Management, LLC Mutual Fund 2026/Q4 +725,755 0.2%
Deerfield Management Company, L.P. Hedge Fund 2026/Q4 +632,000 0.2%
Invesco Capital Management LLC Mutual Fund 2026/Q4 +627,974 1.0%
Quantinno Capital Management LP Mutual Fund 2026/Q4 +594,345 0.2%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
29 Oct 2026 Mark Stetter Independent Director Other Derivative Acquisition +5 – 886
8 Oct 2026 Kristin Peck Chief Executive Officer Other Derivative Acquisition +720 – 66,915
8 Oct 2026 Roxanne Lagano General Counsel Other Derivative Acquisition +367 – 31,315
8 Oct 2026 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +321 – 5,022
8 Oct 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +367 – 2,480
8 Oct 2026 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +52 – 2,349
8 Oct 2026 Rimma Driscoll EVP of Global Strategy, Portfolio Mkt, Busi. Dev Human Health and Platinum Per. Other Derivative Acquisition +277 – 6,551
8 Oct 2026 Keith Sarbaugh Executive VP & Chief Digital and Technology Officer Other Derivative Acquisition +303 – 2,668
8 Oct 2026 Kevin Esch Executive VP and President of Research & Development Other Derivative Acquisition +360 – 1,167
29 Sep 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Sale -274 $69.83 1,588
29 Sep 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Derivative Exercise and Retained +525 – 1,588
16 Sep 2026 Mark Stetter Independent Director Other Derivative Acquisition +342 – 880
30 Aug 2026 James Saccaro Chief Financial Officer Other Derivative Acquisition +81,063 – 81,063
6 Aug 2026 Frank D'Amelio Independent Director Other Disposition -6,650 – 21,458
9 Jul 2026 Wetteny Joseph Special Advisor to the CEO Other Derivative Acquisition +363 – 10,155
9 Jul 2026 Kristin Peck Chief Executive Officer Other Derivative Acquisition +616 – 66,195
9 Jul 2026 Roxanne Lagano General Counsel Other Derivative Acquisition +314 – 30,947
9 Jul 2026 Abhay Nayak Executive VP & President of U.S. Commercial Operations Other Derivative Acquisition +214 – 4,701
9 Jul 2026 Julie Fuller Executive VP, Chief Human Resources Officer & Global Operations Other Derivative Acquisition +314 – 2,113
9 Jul 2026 Jeannette Astorga Executive VP of Corporate Affairs & Chief Sustainability Officer Other Derivative Acquisition +45 – 2,296

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 16,722,420 4.0% 4.8
15 Oct 2026 17,520,176 4.2% 4.1
30 Sep 2026 18,424,459 4.5% 4.1
15 Sep 2026 17,390,071 4.2% 3.8
31 Aug 2026 19,430,882 4.7% 4.1
14 Aug 2026 16,781,231 4.1% 2.0

Discussion

No comments yet — be the first to weigh in on ZTS.

Sign in to join the discussion.

Scroll to Top